Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
Sign Up to like & getrecommendations! Published in 2018 at "PLoS ONE"
DOI: 10.1371/journal.pone.0192812
Abstract: Taxol is a widely used chemotherapy drug used clinically for ovarian cancer, although the response to Taxol among individuals varies due to the heterogeneity among ovarian cancer patients. In this work, we analyzed differences in… read more here.
Keywords: serous ovarian; taxol score; taxol; effect ... See more keywords